NTR is deleted in RIP2-deficient mice. We find that RIP2 gates the signaling output of p75 NTR by competing with TRAF6 for binding to the receptor intracellular domain. In CGNs lacking RIP2, more TRAF6 is associated with p75 NTR , leading to increased JNK-dependent apoptosis. In agreement with this, pharmacological inhibition or genetic ablation of TRAF6 restores cell death levels in CGNs lacking RIP2. These results reveal an unexpected mechanism controlling CGN number and highlight how competitive interactions govern the logic of death receptor function.
INTRODUCTION
Death receptors are characterized by the presence of a globular 6-helix bundle domain in their intracellular region known as the ''death domain'' (Ferrao and Wu, 2012; Park et al., 2007) . Prototypical death receptors include the tumor necrosis factor receptor 1 (TNFR1), the Fas receptor (CD95), and the p75 neurotrophin receptor (p75 NTR ) (also known as nerve growth factor receptor
[NGFR], TNFRSF16, and CD271). Lacking enzymatic activity, death receptors form complexes with intracellular effectors and signal by binding or releasing different components. Death receptor signaling can involve multiple pathways, sometimes with opposing functions. For example, TNFR1 and p75 NTR can induce apoptosis through a pathway that requires JNK (c-Jun N-terminal kinase) activity (Friedman, 2000; Wicovsky et al., 2007; Yoon et al., 1998) or promote survival via the transcription factor NF-kB (nuclear factor kappa-B) (Carter et al., 1996; Khursigara et al., 2001; McCarthy et al., 1998; Vicario et al., 2015) . Although the signaling cascades leading to these effects have been characterized in some detail, the underlying logic that determines which pathway becomes predominant, and under which circumstances, remains unclear. Death domains are relatively small protein domains (typically less than 10 kDa), although many of their intracellular interactors are often much larger (60 kDa or more), so it is likely that many of these interactions are mutually exclusive. p75 NTR is highly expressed in the developing nervous system and upon injury or neurodegeneration in the adult, where it functions as a receptor for members of the neurotrophin family, such as nerve growth factor (NGF) (Dechant and Barde, 2002; Roux and Barker, 2002) . The receptor is present at the neuronal plasma membrane as a dimer stabilized by both covalent and non-covalent interactions (Vilar et al., 2009) . The p75 NTR death domain forms low-affinity homodimers (Lin et al., 2015) that dissociate upon NGF binding (Vilar et al., 2009) to allow the recruitment of intracellular effectors, such as RIP2 (receptor interacting protein 2), a member of the RIP kinase family. RIP2 is a necessary component linking p75 NTR to the NF-kB pathway (Khursigara et al., 2001) , an activity that has been associated to cell survival in some cell types, such as Schwann cells (Khursigara et al., 2001 ) and cerebellar granule neurons (CGNs) (Vicario et al., 2015) . Another major intracellular effector of p75 NTR , TRAF6 (TNFR-associated factor 6), binds to juxtamembrane sequences outside the death domain (Khursigara et al., 1999) . TRAF6 has primarily been implicated in the ability of p75 NTR to induce cell death in a JNK-dependent manner (Geetha et al., 2005; Yeiser et al., 2004) . It is not understood how these two signaling pathways are organized on the p75 NTR molecule or whether they interact, something that ought to be critical, given that they mediate opposed functional outcomes. The mechanisms that determine the final number of neurons in the mature CNS are incompletely understood. Programmed cell death is a crucial event required for the elimination of excess neurons and the formation of proper connections. It is a tightly regulated process, involving several families of extracellular factors, including the neurotrophins and their receptors. However, although the neurotrophic theory has provided a powerful framework to explain programmed cell death in the peripheral nervous system, it has been far less applicable in the brain. CGNs comprise over half of all the neurons in the mammalian brain. They are thought to encode ongoing sensorimotor as well as cognitive information to allow associative learning at their postsynaptic targets, the Purkinje neurons (Becker and Person, 2017) . In the mouse cerebellum, CGNs undergo programmed cell death during the first postnatal week (Wood et al., 1993) , but it is unclear how this process is regulated.
In this study, we have examined the cerebella of mice lacking RIP2 and found increased CGN apoptosis that was mediated by the p75 NTR death receptor. Mechanistically, this resulted from increased association of TRAF6 with p75 NTR , leading to enhanced JNK activity in CGNs lacking RIP2. These findings reveal an unexpected hierarchical relationship between the RIP2 and TRAF6 pathways in the control of CGN survival through the p75 NTR death receptor.
RESULTS
Expression of p75 NTR , NGF, and RIP2 during Postnatal Cerebellar Development Expression of the mRNAs encoding p75 NTR , NGF, and RIP2 during cerebellar postnatal development (from postnatal day 5 [P5] to P60) was analyzed by qPCR. All three transcripts were detected in mouse cerebellum, although they showed different dynamic patterns of expression. p75 NTR mRNA levels were sustained during the first two postnatal weeks but increased thereafter (Figure 1A) . On the other hand, NGF mRNA was highest in the first postnatal week and normalized at lower levels after the second week ( Figure 1B ). RIP2 mRNA expression remained fairly constant during the interval examined ( Figure 1C ). Protein levels, examined by quantitative immunoblotting, showed a few differences compared to the corresponding mRNA patterns. p75 NTR expression was constant and sustained through the ages examined ( Figure 1D ). The levels of mature NGF declined after the second postnatal week ( Figure 1E ). At the same time, the levels of proNGF, the uncleaved NGF precursor protein (Lee et al., 2001) , markedly increased during the second week and remained high thereafter ( Figure 1E ). Interestingly, RIP2 protein levels were seen to increase steadily during this period, with maximal levels in young adult mice ( Figure 1F ). Using combined in situ hybridization (for RIP2 mRNA) and immunohistochemistry (for p75 NTR ) in sections of P7 cerebella, we detected colocalization of the two molecules in the external and internal granule layers (EGL and IGL, respectively; Figure 1G ). As previously described (Friedman et al., 1991), p75 NTR was abundantly expressed by Purkinje cells. However, no RIP2 mRNA expression could be detected in those cells ( Figure 1G ). Importantly, no signal could be detected for either marker in double mutant mice lacking RIP2 and p75 NTR (Figure 1G) . As the EGL is known to exclusively generate CGNs (Carletti and Rossi, 2008) , these data indicate that these neurons co-express p75 NTR and RIP2. This was confirmed by immunoblotting in cell lysates of pure cultures of P5 CGNs ( Figure 1H ).
Increased Cell Death in CGNs of Mice Lacking RIP2 Is Mediated by p75
NTR
We investigated cell death in cerebella of mutant mice lacking RIP2 (ripk2
) by immunohistochemistry for cleaved caspase 3 at P7, P10, and P14. ripk2 À/À mutant mice showed increased cleaved caspase 3 immunoreactivity in both the EGL, which harbors proliferating CGNs, and IGL, containing mature CGNs . This was most prominent at P7, the height of CGNs programmed cell death. We assessed whether CGNs marked by cleaved caspase 3 included mitotic cells by immunostaining and 2G), indicating that there were no changes in cell proliferation in CGNs of the mutant cerebellum. This was confirmed by assessing the ratio of phospho-histone H3 to Ki67 staining in sections of P7 in ripk2 +/+ and ripk2
cerebella (Figures S1A and S1B). The number of BrdU-labeled cells 3 days post-injection (some in EGL, most in IGL) was reduced in the mutants, and this reduction was even more pronounced 7 days after BrdU injection (almost all in IGL; Figure 2G ). Although reduced in number, the relative distribution of BrdU-labeled cells among different cerebellar layers was not different between wild-type and mutant at any time point , confirming that the deficits observed in ripk2 À/À mice are in CGN survival and not migration. These deficits were maintained in the cerebellum of adult (P60) ripk2 À/À mice, as indicated by a decrease of the overall number of NeuN-positive neurons in different cerebellar folia (Figures 2H and 2I) .
Impaired Motor Behaviors Associated with Cerebellar Function in Mice Lacking RIP2
Adult (6-month-old) ripk2 +/+ and ripk2 À/À mice were subjected to a battery of behavioral tests to measure exploratory activity (Foti et al., 2010) , anxiety (Apps and Strata, 2015) , gait (Vinueza Veloz et al., 2015) , and motor learning and function (De Zeeuw and Ten Brinke, 2015; Sergaki et al., 2017 Figures S2G-S2I ), indicating normal locomotor activity and exploratory and anxiety behaviors in ripk2 À/À mutant mice. However, there were significant differences in the learning curves of rotarod training sessions between the two genotypes ( Figure 3A ). After the training, although ripk2 À/À mutants were able to stay on the rod at the fix speed of 20 rpm ( Figure 3B ), they fell more readily than wild-type littermates on a rod accelerating from 4 to 40 rpm ( Figure 3C ). In the gait test, forepaw and hind paw base as well as stride length were similar in mutant and control mice ( Figures 3D-3G ), but the overlap between the forepaw and hind paw was increased in ripk2 À/À mutant mice compared to wild-type littermates ( Figure 3H ), indicating gait defects. Mutant mice did not show tremors or signs of ataxia. Together, these findings indicate impairment in several motor behaviors associated with cerebellar function in mice lacking RIP2.
RIP2 Regulates CGN Survival Cell Autonomously by Gating p75 NTR Responsiveness to Endogenous NGF
After 3 days in vitro (3 DIV), CGNs isolated from P7 ripk2 À/À mutant mice showed a significant increase in cleaved caspase 3 immunoreactivity compared to those derived from wild-type controls or p75 NTRÀ/À mutant mice (Figures 4A and 4B) , in agreement with our findings in vivo. Re-expression of RIP2 in ripk2 À/À mutant neurons by transfection restored cleaved caspase 3 immunoreactivity to wild-type levels ( Figure 4C ), suggesting that RIP2 can regulate CGN survival cell autonomously. We found that both mature NGF (mNGF) and proNGF were endogenously produced in our CGN cultures and could be detected in CGN supernatants after 1 and 2 DIV ( Figure 4D ). There were no differences between the levels of mNGF produced in wild-type and ripk2
À/À mutant CGN cultures ( Figure S3A ). We then tested the functional relevance of the endogenously produced NGF for CGNs survival using function-blocking antibodies (Figures 4E and 4F) . Because untransfected CGNs extracted from the whole cerebellum had shown low levels of cell death in culture (Figure 4B ), we prepared CGNs from cerebellar folia III and X, as these were the most sensitive to ripk2 deletion ( Figure 2E ). This significantly increased the dynamic range of the assay (Figure 4F ), allowing us to more accurately assess the effects of the different blocking antibodies. Antibody MAB256 has been shown to preferentially bind to mNGF (Malerba et al., 2015) and to block its function (Dollé et al., 2003) , and antibody ALM006 can block the activities of both NGF isoforms (Ding et al., 2015; Pundavela et al., 2015) . Blocking mNGF with MAB256 induced cleaved caspase 3 immunoreactivity in wildtype CGNs maintained for 24 hr with the antibody (solid bars in Figure 4F ), suggesting that endogenous mNGF has a pro-survival function in these cultures. As before, CGNs derived from ripk2 À/À mutant mice showed increased cell death under control conditions (open bars in Figure 4F ), but in this case, addition of the anti-mNGF blocking antibody reduced the levels of cleaved caspase 3 (solid bars in Figure 4F ). On the other hand, blocking the function of both mNGF and proNGF with ALM006 had no effect on wild-type neurons but completely counteracted the effect of the RIP2 mutation on CGN death, restoring it to wildtype levels (gray bars in Figure 4F ). Thus, in the presence of RIP2 (i.e., wild-type CGNs), mNGF has pro-survival and proNGF pro-death activity, but both isoforms can induce apoptosis if RIP2 is missing (i.e., ripk2 À/À mutant CGNs). This suggested that the pro-survival effects of mNGF are RIP2 dependent, and the increased cell death observed after blocking mNGF is mediated by proNGF. The anti-mNGF antibody did not increase caspase 3 activity in p75 NTRÀ/À mutant neurons like it did in wild-type cells ( Figure S3B ). This is in agreement with the idea that the increased apoptosis induced by anti-mNGF in wildtype CGNs is mediated by interaction of endogenous proNGF with p75 NTR .
CGN Cell Death Induced by Lack of RIP2 Is Dependent on JNK Activity
Because of its prominent role in death receptor signaling (Friedman, 2000; Wicovsky et al., 2007; Yoon et al., 1998) (Reddy et al., 2013) , was also observed in cultured CGNs lacking RIP2 ( Figures 5C and 5D ). This was reduced upon treatment with function-blocking antibodies against mNGF or total NGF ( Figure 5D ). Moreover, wild-type ripk2 +/+ neurons treated with anti-mNGF, but not with anti-total NGF, blocking antibody also showed elevated c-Jun phosphorylation in Thr 91 ( Figure 5D ), in agreement with the results of caspase 3 activation. Immunoreactivity for activated caspase 3 in cultures of ripk2 À/À mutant CGNs was restored to basal levels upon treatment with the specific JNK inhibitor JNK-IN-8 (Zhang et al., 2012; Figures 5E and 5F) . Together, these results support the involvement of the JNK pathway in CGN cell death induced by lack of RIP2.
RIP2 Gates the Interaction of TRAF6 with p75 NTR to
Regulate CGN Survival Given the involvement of TRAF6 in the regulation of JNK activity downstream of death receptors, we investigated the expression of TRAF6 during cerebellum development and its interaction with p75 NTR in wild-type CGNs and CGNs lacking RIP2. TRAF6 was most highly expressed during the first week of postnatal cerebellar development ( Figure 6A) 6D ) but had no effect on RIP2 ( Figures 6B and 6C ). Immunoprecipitation of p75 NTR from P7 cerebellar extracts consistently recovered higher levels of TRAF6 in ripk2 À/À mutant mice compared to wild-type controls ( Figures 6E and 6F ). These results were confirmed using the proximity ligation assay (PLA) in cultured CGNs from wild-type and ripk2 À/À mice ( Figure 6G and open bars in Figure 6H ). In line with these results, reintroduction of RIP2 by transfection in ripk2 À/À CGNs restored the interaction of TRAF6 with p75 NTR to wild-type levels (gray bars in Mean ± SEM of data from four separate cultures is shown (**p < 0.01 compared to control; unpaired Student's t test). Figure 6H ), a condition that also restored normal levels of cell death in the mutant neurons, as shown earlier ( Figure 4C ). Interestingly, treatment with a cell-permeable TRAF6 decoy peptide that masks the TRAF6 binding site in death receptors (Ye et al., 2002 ) also reduced binding of TRAF6 to p75 NTR in ripk2
CGNs as assessed by PLA ( Figures 6I and 6J ). Under these conditions, the TRAF6 decoy peptide also reduced c-Jun phosphorylation on Thr91 in the mutant neurons ( Figures 6K and 6L ) and restored cell death to wild-type levels ( Figures 7A and 7B) . A similar result was obtained by short hairpin RNA (shRNA) knockdown of TRAF6 ( Figures 7C and S5 ). Collectively, these results indicated that, in the absence of RIP2, enhanced binding of TRAF6 to the p75 NTR death receptor increases CGN cell death.
We considered two possible mechanisms by which RIP2 may gate the interaction of TRAF6 with p75 NTR to regulate CGN survival. As the RIP2 sequence contains a motif (PPENYE) resembling the consensus TRAF6 binding site found in several death receptors (PxxExxAr/Ac; Ar, aromatic; Ac, acidic), including p75 NTR (Vilar, 2017) , it is possible that an interaction between RIP2 and TRAF6 hinders the latter from binding p75 NTR . Alternatively, RIP2 and TRAF6 may compete for binding to p75 NTR .
Although RIP2 and TRAF6 have been shown to interact with different regions of the p75 NTR intracellular domain, steric hindrance may prevent their binding simultaneously to the same receptor molecule, given their relatively large size compared to the p75 NTR juxtamembrane and death domains.
In order to address these possibilities, we generated single and double mutants of RIP2 targeting the main residues in the putative TRAF6 binding site (see Experimental Procedures). We could confirm that RIP2 and TRAF6 can interact with each other by co-immunoprecipitation after overexpression in HEK293 cells ( Figure 7D ). Their interaction was significantly weakened after mutation of the conserved residues in the putative TRAF6 bidding motif ( Figure 7D ). However, both these RIP2 mutants were indistinguishable from wild-type RIP2 at restoring the interaction of TRAF6 with p75 NTR (Figures 7E and 7F ) and the level of cell death ( Figure 7G ) when overexpressed in CGNs derived from ripk2 À/À mutant mice. These data supported the idea that RIP2 gates the interaction of TRAF6 with p75 NTR through a competition mechanism based on steric hindrance on the receptor itself.
DISCUSSION
Despite much research on the function of individual components in the signaling pathways regulated by death receptors, our knowledge of how these pathways are integrated and interact with each other remains scant. In this study, we describe an unexpected mechanism contributing to integrate the function of two key effectors of the p75 NTR death receptor, RIP2 and TRAF6, which mediate opposed functional outcomes, namely cell survival and cell death, respectively. As RIP2 and TRAF6 interact with different regions of the p75 NTR intracellular domain, it has been assumed that they would be able to engage the receptor simultaneously. Unexpectedly, we uncovered a competitive interaction between these two effectors for binding to the p75 NTR , which underlies the physiological regulation of cell death among subpopulations of CGNs in the early stages of cerebellar postnatal development. In the absence of RIP2, more TRAF6 interacted with p75 NTR , leading to increased CGN cell death. This could be restored to normal levels by reintroducing RIP2, removing p75 NTR or TRAF6, preventing TRAF6 from binding to p75 NTR , or blocking endogenously produced NGF ligands in the mutant neurons. Based on these observations, we propose that RIP2 gates the interaction of TRAF6 with p75 NTR to balance pro-survival and pro-death pathways, thereby helping to achieve a physiological level of CGN cell death during normal cerebellar development. The pro-survival function of RIP2 downstream of p75 NTR has been attributed to its ability to regulate the NF-kB pathway (Khursigara et al., 2001) . In agreement with this, we found that mNGF was unable to regulate p65 NFkB nuclear translocation in mutant neurons lacking RIP2. On the other hand, the increased cell death of CGNs lacking RIP2 could be restored to normal levels by blocking TRAF6, either pharmacologically or genetically, suggesting that the cell survival effects afforded by the RIP2 pathway downstream of p75 NTR may not require regulation of NF-kB signaling and could simply be due to displacement of TRAF6 from the receptor. In wild-type CGNs expressing RIP2, endogenously produced mNGF and proNGF displayed opposed pro-survival and procell death roles, respectively, suggesting that cleavage of the NGF precursor protein, and hence the ratio between mNGF and proNGF, may be a key determinant of CGN survival in postnatal cerebellar development. Interestingly, as the proNG/mNGF ratio increased in postnatal cerebellum ( Figure 1E) , so did the level of RIP2 (Figure 1F ), suggesting a possible mechanism to limit the surge of CGN cell death to the first two weeks of postnatal development. In the absence of RIP2, both mNGF and proNGF could induce apoptosis, explaining the enhanced cell death observed in CGNs of ripk2 À/À mutant mice.
CGNs outnumber all other brain neurons combined and are thought to encompass heterogeneous subpopulations (Curtice et al., 2016) . Recent findings have revealed their capacity of encoding complex aspects of reward and predictive information, in addition to classical sensorimotor encoding (Giovannucci et al., 2017; Wagner et al., 2017) , beginning to provide an explanation for their large numbers. It would therefore seem important to understand the mechanisms that regulate CGN survival. Although deletion of neurotrophin receptors TrkB and TrkC was initially reported to enhance CGN apoptosis, these mice also showed enlargement of the granule layer and a marked increase in CGN number (Minichiello et al., 1999) , suggesting alternative effects on proliferation or differentiation. Our present results show that RIP2 gates p75 NTR signaling to affect the survival of approximately 20% of CGNs in the adult brain (estimation based on data from Figure 2I ). Interestingly, CGN loss was not homogeneous across different cerebellar folia of mice lacking RIP2; e.g., although no significant difference could be found in folia VIII, over 50% cell loss was detected in folia X of the mutant mice. These results indicate a significant degree of heterogeneity in the survival requirements of CGNs and support the emerging notion of functional diversity among CGN subpopulations.
In summary, we describe a mechanism orchestrating the hierarchical activation of pro-survival and pro-cell death pathways in the p75 NTR death receptor, which contributes to determine the number of cerebellar CGNs that survive postnatal cell death. The interplay between RIP2 and TRAF6 in p75 NTR signaling identified in this study suggests that competitive interactions are a key feature of death receptor function.
EXPERIMENTAL PROCEDURES Animals
Mice were housed in a 12-hr light/dark cycle and fed a standard chow diet.
The following transgenic mouse lines were used: p75 NTR knockout mice (Lee et al., 1994) and RIP2 knockout mice . RIP2 and p75 NTR mutant mice were maintained in a C57Bl6 background. Mice of both sexes were used for the experiments. For BrdU experiments, mice were injected with 50 mg/kg and sacrificed 2 hr, 3 days, or 7 days post-injection. Animal protocols were approved by Stockholms Norra Djurfö rsö ksetiska Nä mnd and are in accordance with the ethical guidelines of the Karolinska Institute.
Plasmids
Control shRNA and 4 unique 29-mer shRNA constructs targeting mouse TRAF6 in retroviral GFP vector plasmids were purchased from Origene. Human RIP2 in pC1 vector was obtained from Dr. Moses Chao's laboratory. Mutations in RIP2 were introduced using QuickChange Site-Directed Mutagenesis Kit (Stratagene, UK) and verified by DNA sequencing. In the TRAF6-binding site, the RIP2 wild-type sequence corresponds to IYMPPENYE, mutant 1 to IYMTPENYE, and mutant 2 to IYMTPANYE. Normal expression of all constructs and interaction to TRAF6 was verified in HEK293 cells by immunoblotting.
Cell Culture P7 mouse cerebella were separated from the rest of the brain and placed into a plate with cold PBS. Whole cerebella or selected folia were digested with trypsin for extraction of CGNs. Folia III and X dissected under a dissection microscope following anatomical images given by Kim and Scott (2014) and White and Sillitoe (2013) . CGNs were plated at a density of 40,000 cells per coverslip coated with poly-D-lysine (Sigma) in a 24-well plate (Starlab) in Basal Medium Eagle (BME) supplemented with 10% fetal calf serum (Gibco), 25 mM KCl (Sigma), 1 mM glutamine (Gibco), and 2 mg/mL gentamicin (Invitrogen). The cells were treated after 2 DIV. For assessing cleaved caspase 3, neurons were treated for 24 hr with the indicated substances and then labeled with antibodies against cleaved caspase 3 (Cell Signaling Technology; 9761; 1:400) and b-III tubulin (R&D Systems; MAB1195; 1:1,000) and counterstained with DAPI. Images were taken using a Zeiss fluorescence microscope and quantified to obtain percentage cells positive for cleaved caspase 3 relative to DAPI. To collect protein for immunoblotting, neurons were cultured at a higher density ($200,000 neurons per well) in a 48-well plate for 2 days and then serum and KCl deprived for 30 min. The neurons were then treated with the indicated substances for 15 min. To collect protein for immunoprecipitation, CGNs were cultured at higher density ($900,000 neurons per well) in 6-well plates for 2 days. Neurons were then deprived of serum and KCl for 30 min and treated with NGF for 5 min. Primary neurons from ripk2 +/+ and ripk2 À/À mice were derived from P7 littermate pups generated by crossing heterozygous mice. CGNs were transfected after 2 DIV with Lipofectamine LTX (Invitrogen; Cat Immunoblots were developed using the ECL Advance Western Blotting Detection kit (Life Technologies) and exposed to Kodak X-Omat AR films. Image analysis and quantification of band intensities were done with ImageQuant software (GE Healthcare). For immunoprecipitation, cells were lysed with RIPA buffer containing protease inhibitor (Roche) for 1 hr. Total protein was collected and incubated with anti-p75 NTR (Neuromics; GT15057; 1:500) overnight at 4 C and then incubated with Sepharose Protein-G beads (GE Healthcare). Samples were then prepared for immunoblotting as described above. Determination of levels of secreted mature and total NGF was done using ELISA kits from Novus (for mature NGF; KA0400) or CUSABIO (for proNGF; equation 027721MO).
Immunohistochemistry, Immunocytochemistry, and In Situ Hybridization For immunohistochemistry, animals were perfused with PBS followed by 4% paraformaldehyde. Brains were collected and post-fixed in 4% paraformaldehyde for 16 hr and then cryoprotected in 30% sucrose before being embedded in OCT and frozen at À80 C overnight. The tissue was serially sectioned on a cryostat at 10 or 20 mm in the sagittal plane. Midline sections were mounted onto electrostatic charged slides (Leica Microsystems), blocked with 5% donkey serum containing 0.3% Triton X-100 in PBS for 1 hr at room temperature, and then incubated for 16 hr at 4 C with primary antibodies. The sections were washed in PBS before being incubated with appropriate secondary antibody. For quantification of cleaved-caspase-3-positive cells, 10-mm sections through the cerebellum of P60 ripk2 +/+ and ripk2 À/À animals were stained for NeuN (Millipore; MAB377; 1:200) and DAPI at the same time to ensure that they were stained in an identical manner. An area of 25,464 mm 2 for each image from folia III, VIII, and X was imaged, and the total number of NeuN-positive cells was quantified using NIH ImageJ software. For immunocytochemistry, neuron cultures were fixed in 4% paraformaldehyde and 4% sucrose for 15 min and then washed with PBS before incubation in 5% BSA and 0.3% Triton X-100 (Sigma) in PBS for 1 hr at room temperature for blocking nonspecific binding and permeabilizing the cells. Neurons were then incubated overnight with primary antibody in 1% blocking solution at 4 C. After washing with PBS, the cultures were incubated with the appropriate secondary antibody. The primary antibodies were as follows: polyclonal anti-p75 was linearized with Spe1 and transcribed with T7 polymerase, and the sense probe was linearized with Xho1 and transcribed with Sp6 polymerase using a BIOT-NTP labeling kit (Roche). P7 pups were perfused as above. Brain tissue was collected, postfixed, and cryoprotected as above. Sagittal serial sections of 30 mm were obtained on a cryostat. Free-floating sections were washed in PBS followed by 53 saline-sodium citrate buffer (SCC) (0.75 M NaCl and 75 mM sodium citrate). The sections were then prehybridized for 2 hr at 50 C in SCC buffer containing 50% deionized formamid and 40 mg/mL salmon DNA and then incubated with sense or antisense probes at 75 C for 10 min, followed by 58 C for 16 hr. After washing at 65 C for total of 2 hr, the sections were treated with H 2 O 2 to quench endogenous autofluorescence, blocked in 0.5% tyramide signal amplification solution (TSA; TSA biotin kit; PerkinElmer) for 30 min, and stained with Streptavidin-HRP (1:100) at room temperature. After several washes, the sections were incubated in biotin-tyramide (1:100) reconstituted in amplification diluent (TSA biotin kit; PerkinElmer) for 10 min. After further washes, the sections were stained with Streptavidin-488 (Life Technologies; S32354; 1:1,500) for 90 min. Sections were then washed and prepared for immunohistochemistry as described above.
Proximity Ligation Assay
After transfection or treatment, CGNs were fixed for 15 min in 4% paraformaldehyde (PFA)/4% sucrose, permeabilized, and blocked in 10% normal donkey serum and 0.3% Triton X-100 in PBS. Cells were then incubated overnight at 4 C with anti-p75 NTR (Promega; G323A; 1:300), anti-TRAF6 (Santa Cruz;
sc-8490; 1:100), and anti-MAP2 (Abcam; ab5392; 1:4,000) antibodies in PBS supplemented with 3% BSA. The Duolink In Situ Proximity Ligation kit (Sigma) was used as per the manufacturer's instructions with fluorophore-conjugated secondary antibody to recognize MAP2 (Molecular Probes; 703-606-155; 1:2,000) included during the amplification step. Transfected and MAP2-positive cells were imaged with an LSM Imager Z2 confocal microscope (Zeiss) to detect PLA signals. Puncta on transfected and MAP2-positive somas were quantified using NIH ImageJ software.
Behavioral Analysis
All behavioral observations and measurements were performed blind to the genotype. Six-month-old ripk2 +/+ (n = 8) and ripk2 À/À (n = 8) mice were used for the study. As no sex differences were observed within the same genotype for any of the tests, the results of both sexes were pooled together. In all cases, mice were acclimatized to the behavioral room for at least 20 min before testing and all apparatuses were cleaned with 70% ethanol between animals. Rotarod test was performed on model 47600 (Ugo Basile) following a protocol previously described (Yamazaki et al., 2015) . Mice were first subjected to 3 training sessions each of 4 training trials during 3 consecutive days. Each training trial had a maximum duration of 60 s at a fixed speed of 20 rpm with an inter-trial time of 30 min. In the test day, mice were first subjected to a 20-rpm fixed speed trial with a maximum length of 60 s followed by three trials of accelerating speed (from 4 to 40 rpm over 5 min) with a maximum length of 360 s and 1 hr inter-trial period. In all cases, a trial ended when either the mouse fell off the rod, the maximum latency was reached, or the animal rotated, hugging the rod for more than 4 rotations. For the footprint test, the hind-and forepaws of each mouse were coated with red and black nontoxic water-based paints, respectively. Mice were then allowed to walk down an enclosed runway line on a sheet of white paper. Two trials were performed in two consecutive days, and 3-6 steps from the middle portion of each run were measured for (1) stride length (average distance of forward movement between each stride), (2) forepaw and (3) hind paw base width (average distance between left and right front or hind footprints), and (4) overlap (to measure uniformity of step alternation). For evaluation of overlap, a zero value was assigned when the center of the hind footprint fell on top of the preceding front footprint. When the footprints did not overlap, the distance between the centers of the footprints was measured. In all cases, the mean values of the two trials were used for subsequent analysis. 
Statistical Analysis

